CD137, suggested to be involved in impaired regulatory function of Treg and plasmacytoid DC in MS patients, is elevated in MS individuals, while FoxP3 is impaired in RRMS [180]. The gene discussed is TNFRSF9; the disease is myeloid sarcoma.